Adults with nonspecific low back pain who wore a soft, adjustable lumbar belt for 12 weeks on top of usual care ended up less disabled, in less pain, and less likely to be taking pain medication than people who got usual care alone, according to a randomized trial published August 3, 2026 in JAMA Network Open. The trial ran at 17 French medical centers and enrolled 168 adults whose back pain episode had lasted 1 to 6 months.
Key takeaways
- Disability scores improved by 10.0 points with the belt versus 5.3 points with usual care, a between-group difference of 4.7 points.
- Pain medication use over 12 weeks dropped from 67.6% of patients on usual care to 50.6% with the belt, about 17 fewer users per 100 people.
- The trial was open-label with no fake belt for comparison, so expectation could account for part of the benefit.
What the study found
Researchers randomly assigned 168 adults, average age 49 and 60.1% women, to wear a nonrigid lumbar belt for 12 weeks plus usual care, or usual care with no device. Usual care meant encouragement to stay active plus the usual pain medicines. The trial is registered as NCT04701073.
The main measure was the Oswestry Disability Index, a 0 to 100 score of how much back pain interferes with daily tasks like lifting, walking, and sitting. Higher is worse. Over 12 weeks, scores fell 10.0 points with the belt and 5.3 points with usual care. The gap of 4.7 points was very likely somewhere between 0.9 and 8.4 points in the belt’s favor (95% CI, 0.9 to 8.4), with roughly a 1 in 100 chance a difference that large came from chance alone (P = .01).
Pain scores moved the same way. On the 100-point pain rating used in the trial, the belt group reported 8.7 points less pain at rest and 10.0 points less during activity, each with about a 2 in 100 chance of being a fluke (P = .02 for both).
The medication result was the most concrete. Over 12 weeks, 41 of 81 belt patients (50.6%) used pain medication versus 50 of 74 usual care patients (67.6%): about a 25% lower rate in relative terms, 17 fewer users per 100 in absolute terms. Put another way, about 6 people would need to wear the belt for 1 more person to skip pain medication over those 12 weeks. There is about a 3 in 100 chance that gap is coincidence (P = .03). No serious device-related side effects occurred.
Dr. Kumar’s take
Back braces have been discouraged for years on the theory that they let the core muscles go slack. This trial does not settle that. Twelve weeks is not long enough to see whether daily bracing costs someone trunk strength over a year or five.
The bigger limitation is the design. Patients knew whether they had a belt on, and there was no sham belt for comparison. Belief in a treatment moves pain and disability scores on its own, and here that channel is wide open. The honest read is a modest benefit of uncertain mechanism, not a green light for indefinite bracing.
Size matters. Both groups improved on the Oswestry index, 10.0 points with the belt and 5.3 points without, leaving 4.7 points between them: a real signal in the data, a small one in a person’s life.
The medication finding is where this gets clinically useful. A 25% relative drop in the number of people reaching for pain medicine is the kind of tradeoff worth discussing with someone trying to stay off opioids or avoid an operation. A belt is cheap, reversible, and carried no serious device risk here. The trial also excluded people with sciatica-type nerve pain, known disc degeneration on MRI, prior spine surgery, and work-related injury, so it says nothing about those situations.
What it means for you
If your back pain is the ordinary muscular kind, has lasted one to six months, and does not shoot down your leg, a soft adjustable lumbar belt is a reasonable thing to try alongside staying active. The trial added the belt to advice to keep moving rather than replacing it.
Treat it as a bridge, not a permanent fixture. Use it for the hours when pain limits what you can do, and keep working on the activity it has been blocking. If your pain radiates into a leg, follows an injury, or comes with numbness, weakness, or bladder changes, that is a different problem and needs an evaluation, not a belt.
Nondrug options for chronic pain keep stacking up evidence like this, and team-based care recently beat group therapy for chronic pain in veterans. The pattern is consistent: modest gains, low risk, and the most value in helping people take less medication.